Elanco Animal Health IncorporatedELANNYSE
Loading
R&D Expenses Over TimeStable
Percentile Rank90
3Y CAGR+4.7%
5Y CAGR+2.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+4.7%/yr
vs +6.8%/yr prior
5Y CAGR
+2.4%/yr
Consistent
Acceleration
-2.2pp
Decelerating
Percentile
P90
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$368.00M+7.0%
2024$344.00M+5.2%
2023$327.00M+1.9%
2022$321.00M-13.0%
2021$369.00M+12.8%
2020$327.00M+21.1%
2019$270.10M+9.5%
2018$246.60M-2.0%
2017$251.70M-5.3%
2016$265.80M-